65 related articles for article (PubMed ID: 4052141)
1. [Pharmacokinetics of 5-ethyl-2'-desoxyuridine in the rat].
Hempel B; Kaul R
Arzneimittelforschung; 1985; 35(7):1058-60. PubMed ID: 4052141
[TBL] [Abstract][Full Text] [Related]
2. [Isolation and identification of metabolites of 5-ethyl-2'-deoxyuridine from rat urine].
Kaul R; Hempel B
Arzneimittelforschung; 1985; 35(7):1055-7. PubMed ID: 4052140
[TBL] [Abstract][Full Text] [Related]
3. [Metabolic studies of 5-ethyl-2'-deoxyuridine with liver extract, liver cells and liver cell culture].
Buchele A; Schloz U; Müller-Wellensiek A; Voelter W
Arzneimittelforschung; 1989 Feb; 39(2):220-2. PubMed ID: 2543421
[TBL] [Abstract][Full Text] [Related]
4. Elimination of the antiviral drug 5-ethyl-2'-deoxyuridine by the isolated perfused rat liver.
Joly JM; Williams WM
Drug Metab Dispos; 1991; 19(6):1058-65. PubMed ID: 1687011
[TBL] [Abstract][Full Text] [Related]
5. 2-14C-1-(2'-deoxy-beta-D-ribofuranosyl)-5-ethyluracil: synthesis and biotransformation in rats.
Kaul R; Kiefer G; Erhardt S; Hempel B
J Pharm Sci; 1980 May; 69(5):531-4. PubMed ID: 7381737
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and bioavailability of 5-ethyl-2'-deoxyuridine and its novel (5R,6R)-5-bromo-6-ethoxy-5,6-dihydro prodrugs in mice.
Cheraghali AM; Kumar R; Knaus EE; Wiebe LI
Drug Metab Dispos; 1995 Feb; 23(2):223-6. PubMed ID: 7736915
[TBL] [Abstract][Full Text] [Related]
7. Deoxyribosyl exchange reactions leading to the in vivo generation and regeneration of the antiviral agents (E)-5-(2-bromovinyl)-2'-deoxyuridine, 5-ethyl-2'-deoxyuridine and 5-(2-chloroethyl)-2'-deoxyuridine.
Desgranges C; De Clercq E; Razaka G; Drouillet F; Belloc I; Bricaud H
Biochem Pharmacol; 1986 May; 35(10):1647-53. PubMed ID: 3011010
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacokinetic studies of 14C-labeled epervudine in rats].
Dereszlay I; Vereczkey L
Acta Pharm Hung; 1993 Jul; 63(4):222-6. PubMed ID: 8379338
[TBL] [Abstract][Full Text] [Related]
9. [Pharmacokinetic studies of epervudine in rats using HPLC].
Dereszlay I; Mészáros S; Csárdi A; Pátfalusi M; Vereczkey L
Acta Pharm Hung; 1993 Jul; 63(4):227-36. PubMed ID: 8379339
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological studies on 5-methoxymethyl-2'-deoxyuridine: a new antiviral agent.
Meldrum JB; Gupta VS; Taneja AK; Sisodia CS
J Pharmacol Exp Ther; 1981 Feb; 216(2):275-80. PubMed ID: 7463349
[TBL] [Abstract][Full Text] [Related]
11. Combined antiviral effects of flavonoids and 5-ethyl-2'-deoxyuridine on the multiplication of herpesviruses.
Mucsi I
Acta Virol; 1984 Sep; 28(5):395-400. PubMed ID: 6151353
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biotransformation, pharmacokinetics, and antiviral properties of 5-ethyl-5-halo-6-methoxy-5,6-dihydro-2'-deoxyuridine diastereomers.
Cheraghali AM; Kumar R; Wang L; Knaus EE; Wiebe LI
Biochem Pharmacol; 1994 Apr; 47(9):1615-25. PubMed ID: 8185676
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biodistribution of [4-14C]-5-bromo-6-methoxy-5,6-dihydro-prodrug derivatives of 5-ethyl-2'-deoxyuridine.
Cheraghali AM; Morin KW; Kumar R; Knaus EE; Wiebe LI
Drug Des Discov; 1994 Jul; 12(1):53-61. PubMed ID: 7578807
[TBL] [Abstract][Full Text] [Related]
14. [Experimental and clinical results with the virostatic agent 5-ethyl-2'-deoxyuridine].
Riehm E; Gauri KK
Ber Zusammenkunft Dtsch Ophthalmol Ges; 1969; 69():543-5. PubMed ID: 5395099
[No Abstract] [Full Text] [Related]
15. Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the rat.
Choudhury R; Epemolu RO; Rai BL; Hider RC; Singh S
Drug Metab Dispos; 1997 Mar; 25(3):332-9. PubMed ID: 9172951
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of 3-[bis(2-hydroxyethyl)amino]acetophenone [4,5-diphenyloxazolyl-(2)]hydrazone (ZIMET 98/69) in rats.
Amlacher R; Horn U; Kramarczyk K; Ulbricht H; Hoffmann H
Pharmazie; 1982 Jan; 37(1):33-5. PubMed ID: 6122223
[TBL] [Abstract][Full Text] [Related]
17. Identification of a plasma metabolite of 5-(2-bromo-E-ethenyl)-2'-deoxyuridine.
Robinson Y; Gerry N; Brownsill RD; Vose CW
Biomed Mass Spectrom; 1984 Apr; 11(4):199-201. PubMed ID: 6733256
[TBL] [Abstract][Full Text] [Related]
18. Absorption, disposition kinetics, and metabolic pathways of cyclohexene oxide in the male Fischer 344 rat and female B6C3F1 mouse.
Sauer JM; Bao J; Smith RL; McClure TD; Mayersohn M; Pillai U; Cunningham ML; Sipes IG
Drug Metab Dispos; 1997 Mar; 25(3):371-8. PubMed ID: 9172957
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the antimalarial drug, AQ-13, in rats and cynomolgus macaques.
Ramanathan-Girish S; Catz P; Creek MR; Wu B; Thomas D; Krogstad DJ; De D; Mirsalis JC; Green CE
Int J Toxicol; 2004; 23(3):179-89. PubMed ID: 15204721
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of aminomethylpropanol in rats following oral and a novel dermal study design.
Saghir SA; Clark AJ; McClymont EL; Staley JL
Food Chem Toxicol; 2008 Feb; 46(2):678-87. PubMed ID: 17961896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
